ApprovalTrail

Natural health product · NPN 80136628

Menpify

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed December 3, 2024.
Natural Product Number (NPN)
80136628
Licence holder
Clinmedics Co., Ltd.
Dosage form
Tablet
Route
Oral
Licensing route
General (non-traditional)
First licensed
December 3, 2024

Also sold as

Other product names on the same licence.

  • Menpify Tablet

Medicinal ingredients

Per dosage unit, as licensed.

IngredientAmount
L-Arginine125 mg
Vitamin E60 mg at
Vitamin E90 IU
Zinc20 mg
All-trans-lycopene3 mg
L-Carnitine220 mg
Folate400 micrograms
Selenium30 micrograms
L-Glutathione40 mg
2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl7.5 mg

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

  • Helps in energy metabolism/(and) tissue formation. Helps to form red blood cells. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal function of the thyroid gland Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. L-Arginine is (a non-essential amino acid) involved in protein synthesis.

Non-medicinal ingredients

Silicon dioxide; Magnesium stearate; Microcrystalline cellulose; Stearic acid; Hydroxypropylmethylcellulose; Titanium dioxide